Phase 2 Autoimmune Hemolytic Anemia Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study
Venous Thromboembolic DiseaseAutoimmune Hemolytic AnemiaProlonged Anticoagulation
Centre Hospitalier Universitaire Dijon72 enrolled1 locationNCT05089227
Recruiting
Phase 1Phase 2
A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
Autoimmune Hemolytic AnemiaEvans SyndromeAutoimmune Cytopenia+1 more
Keymed Biosciences Co.Ltd158 enrolled3 locationsNCT07175493
Recruiting
Phase 2
Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA
Warm Autoimmune Hemolytic Anemia
Chen Miao22 enrolled1 locationNCT05922839
Recruiting
Phase 2
Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaAutoimmune Hemolytic Anemia+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto45 enrolled3 locationsNCT05694312